Acta Neuropathologica Communications-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2184041, encodeId=63552184041ea, content=这个杂志状态是Under Review是不是是内审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ef8420701, createdName=ms5000000487338220, createdTime=Fri Jan 26 09:31:43 CST 2024, time=2024-01-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2180748, encodeId=43f12180e48f4, content=准备投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:35:20 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180747, encodeId=952d2180e4789, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:34:50 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180745, encodeId=d8eb2180e4525, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:34:30 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140289, encodeId=b81d214028956, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：AD发病机制 经验分享：非常友好期刊，文章质量很好，侧重神经系统疾病发病机制的研究。审稿人也非常友好，提出了很多好的建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f491548190, createdName=hbzyy, createdTime=Thu Jun 01 10:50:16 CST 2023, time=2023-06-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1217936, encodeId=1abc121e93659, content=想请问一下这个杂志在投稿过程中Research Square author dashboard这个步骤，会产生pre-print这个东西吗？因为pre-print很麻烦，是无法撤回的。他的选项只有同意，没其他的，选了同意会产生什么不好的结果？谢谢解惑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f716485572, createdName=ms7000001493124412, createdTime=Sun May 08 20:15:36 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217933, encodeId=79fc121e933e4, content=想请问一下各位投稿这个杂志的时候Research Square author dashboard这一步会带来什么影响吗？会不会生成pre-print这个东西？因为pre-print是一个不可逆的步骤, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f716485572, createdName=ms7000001493124412, createdTime=Sun May 08 20:07:33 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107259, encodeId=3f03110e259d2, content=评审和期刊编辑一般会询问什么问题？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107260, encodeId=8b81110e260de, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588816, encodeId=9f6358881649, content=你好，想咨询一下这个杂志对创新性要求高吗？痞布二马 2020-01-28 23:32:00 发表: 很好的期刊，一审39天给了小修，虽然是小修，但审稿人真的很认真，两个审稿人共给出30多条意见，细节很多，12天修回后，3天接收, beContent=痞布二马 2020-01-28 23:32:00 发表: 很好的期刊，一审39天给了小修，虽然是小修，但审稿人真的很认真，两个审稿人共给出30多条意见，细节很多，12天修回后，3天接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/09/20/851c1d5009f417324fb4659385cdb06b.jpg, createdBy=a1862291685, createdName=121e9784m68暂无昵称, createdTime=Tue Apr 14 00:00:00 CST 2020, time=2020-04-14, status=1, ipAttribution=)]

2024-01-26 ms5000000487338220 来自浙江省

这个杂志状态是Under Review是不是是内审？

16 0

[GetPortalCommentsPageByObjectIdResponse(id=2184041, encodeId=63552184041ea, content=这个杂志状态是Under Review是不是是内审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ef8420701, createdName=ms5000000487338220, createdTime=Fri Jan 26 09:31:43 CST 2024, time=2024-01-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2180748, encodeId=43f12180e48f4, content=准备投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:35:20 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180747, encodeId=952d2180e4789, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:34:50 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180745, encodeId=d8eb2180e4525, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:34:30 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140289, encodeId=b81d214028956, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：AD发病机制 经验分享：非常友好期刊，文章质量很好，侧重神经系统疾病发病机制的研究。审稿人也非常友好，提出了很多好的建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f491548190, createdName=hbzyy, createdTime=Thu Jun 01 10:50:16 CST 2023, time=2023-06-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1217936, encodeId=1abc121e93659, content=想请问一下这个杂志在投稿过程中Research Square author dashboard这个步骤，会产生pre-print这个东西吗？因为pre-print很麻烦，是无法撤回的。他的选项只有同意，没其他的，选了同意会产生什么不好的结果？谢谢解惑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f716485572, createdName=ms7000001493124412, createdTime=Sun May 08 20:15:36 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217933, encodeId=79fc121e933e4, content=想请问一下各位投稿这个杂志的时候Research Square author dashboard这一步会带来什么影响吗？会不会生成pre-print这个东西？因为pre-print是一个不可逆的步骤, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f716485572, createdName=ms7000001493124412, createdTime=Sun May 08 20:07:33 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107259, encodeId=3f03110e259d2, content=评审和期刊编辑一般会询问什么问题？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107260, encodeId=8b81110e260de, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588816, encodeId=9f6358881649, content=你好，想咨询一下这个杂志对创新性要求高吗？痞布二马 2020-01-28 23:32:00 发表: 很好的期刊，一审39天给了小修，虽然是小修，但审稿人真的很认真，两个审稿人共给出30多条意见，细节很多，12天修回后，3天接收, beContent=痞布二马 2020-01-28 23:32:00 发表: 很好的期刊，一审39天给了小修，虽然是小修，但审稿人真的很认真，两个审稿人共给出30多条意见，细节很多，12天修回后，3天接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/09/20/851c1d5009f417324fb4659385cdb06b.jpg, createdBy=a1862291685, createdName=121e9784m68暂无昵称, createdTime=Tue Apr 14 00:00:00 CST 2020, time=2020-04-14, status=1, ipAttribution=)]

2024-01-11 ms2000000316260396 来自广东省

准备投稿

15 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2184041, encodeId=63552184041ea, content=这个杂志状态是Under Review是不是是内审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ef8420701, createdName=ms5000000487338220, createdTime=Fri Jan 26 09:31:43 CST 2024, time=2024-01-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2180748, encodeId=43f12180e48f4, content=准备投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:35:20 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180747, encodeId=952d2180e4789, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:34:50 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180745, encodeId=d8eb2180e4525, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:34:30 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140289, encodeId=b81d214028956, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：AD发病机制 经验分享：非常友好期刊，文章质量很好，侧重神经系统疾病发病机制的研究。审稿人也非常友好，提出了很多好的建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f491548190, createdName=hbzyy, createdTime=Thu Jun 01 10:50:16 CST 2023, time=2023-06-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1217936, encodeId=1abc121e93659, content=想请问一下这个杂志在投稿过程中Research Square author dashboard这个步骤，会产生pre-print这个东西吗？因为pre-print很麻烦，是无法撤回的。他的选项只有同意，没其他的，选了同意会产生什么不好的结果？谢谢解惑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f716485572, createdName=ms7000001493124412, createdTime=Sun May 08 20:15:36 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217933, encodeId=79fc121e933e4, content=想请问一下各位投稿这个杂志的时候Research Square author dashboard这一步会带来什么影响吗？会不会生成pre-print这个东西？因为pre-print是一个不可逆的步骤, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f716485572, createdName=ms7000001493124412, createdTime=Sun May 08 20:07:33 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107259, encodeId=3f03110e259d2, content=评审和期刊编辑一般会询问什么问题？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107260, encodeId=8b81110e260de, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588816, encodeId=9f6358881649, content=你好，想咨询一下这个杂志对创新性要求高吗？痞布二马 2020-01-28 23:32:00 发表: 很好的期刊，一审39天给了小修，虽然是小修，但审稿人真的很认真，两个审稿人共给出30多条意见，细节很多，12天修回后，3天接收, beContent=痞布二马 2020-01-28 23:32:00 发表: 很好的期刊，一审39天给了小修，虽然是小修，但审稿人真的很认真，两个审稿人共给出30多条意见，细节很多，12天修回后，3天接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/09/20/851c1d5009f417324fb4659385cdb06b.jpg, createdBy=a1862291685, createdName=121e9784m68暂无昵称, createdTime=Tue Apr 14 00:00:00 CST 2020, time=2020-04-14, status=1, ipAttribution=)]

2024-01-11 ms2000000316260396 来自广东省

11

13 0

[GetPortalCommentsPageByObjectIdResponse(id=2184041, encodeId=63552184041ea, content=这个杂志状态是Under Review是不是是内审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ef8420701, createdName=ms5000000487338220, createdTime=Fri Jan 26 09:31:43 CST 2024, time=2024-01-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2180748, encodeId=43f12180e48f4, content=准备投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:35:20 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180747, encodeId=952d2180e4789, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:34:50 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180745, encodeId=d8eb2180e4525, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:34:30 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140289, encodeId=b81d214028956, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：AD发病机制 经验分享：非常友好期刊，文章质量很好，侧重神经系统疾病发病机制的研究。审稿人也非常友好，提出了很多好的建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f491548190, createdName=hbzyy, createdTime=Thu Jun 01 10:50:16 CST 2023, time=2023-06-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1217936, encodeId=1abc121e93659, content=想请问一下这个杂志在投稿过程中Research Square author dashboard这个步骤，会产生pre-print这个东西吗？因为pre-print很麻烦，是无法撤回的。他的选项只有同意，没其他的，选了同意会产生什么不好的结果？谢谢解惑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f716485572, createdName=ms7000001493124412, createdTime=Sun May 08 20:15:36 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217933, encodeId=79fc121e933e4, content=想请问一下各位投稿这个杂志的时候Research Square author dashboard这一步会带来什么影响吗？会不会生成pre-print这个东西？因为pre-print是一个不可逆的步骤, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f716485572, createdName=ms7000001493124412, createdTime=Sun May 08 20:07:33 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107259, encodeId=3f03110e259d2, content=评审和期刊编辑一般会询问什么问题？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107260, encodeId=8b81110e260de, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588816, encodeId=9f6358881649, content=你好，想咨询一下这个杂志对创新性要求高吗？痞布二马 2020-01-28 23:32:00 发表: 很好的期刊，一审39天给了小修，虽然是小修，但审稿人真的很认真，两个审稿人共给出30多条意见，细节很多，12天修回后，3天接收, beContent=痞布二马 2020-01-28 23:32:00 发表: 很好的期刊，一审39天给了小修，虽然是小修，但审稿人真的很认真，两个审稿人共给出30多条意见，细节很多，12天修回后，3天接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/09/20/851c1d5009f417324fb4659385cdb06b.jpg, createdBy=a1862291685, createdName=121e9784m68暂无昵称, createdTime=Tue Apr 14 00:00:00 CST 2020, time=2020-04-14, status=1, ipAttribution=)]

2024-01-11 ms2000000316260396 来自广东省

1

17 0

[GetPortalCommentsPageByObjectIdResponse(id=2184041, encodeId=63552184041ea, content=这个杂志状态是Under Review是不是是内审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ef8420701, createdName=ms5000000487338220, createdTime=Fri Jan 26 09:31:43 CST 2024, time=2024-01-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2180748, encodeId=43f12180e48f4, content=准备投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:35:20 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180747, encodeId=952d2180e4789, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:34:50 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180745, encodeId=d8eb2180e4525, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:34:30 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140289, encodeId=b81d214028956, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：AD发病机制 经验分享：非常友好期刊，文章质量很好，侧重神经系统疾病发病机制的研究。审稿人也非常友好，提出了很多好的建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f491548190, createdName=hbzyy, createdTime=Thu Jun 01 10:50:16 CST 2023, time=2023-06-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1217936, encodeId=1abc121e93659, content=想请问一下这个杂志在投稿过程中Research Square author dashboard这个步骤，会产生pre-print这个东西吗？因为pre-print很麻烦，是无法撤回的。他的选项只有同意，没其他的，选了同意会产生什么不好的结果？谢谢解惑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f716485572, createdName=ms7000001493124412, createdTime=Sun May 08 20:15:36 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217933, encodeId=79fc121e933e4, content=想请问一下各位投稿这个杂志的时候Research Square author dashboard这一步会带来什么影响吗？会不会生成pre-print这个东西？因为pre-print是一个不可逆的步骤, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f716485572, createdName=ms7000001493124412, createdTime=Sun May 08 20:07:33 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107259, encodeId=3f03110e259d2, content=评审和期刊编辑一般会询问什么问题？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107260, encodeId=8b81110e260de, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588816, encodeId=9f6358881649, content=你好，想咨询一下这个杂志对创新性要求高吗？痞布二马 2020-01-28 23:32:00 发表: 很好的期刊，一审39天给了小修，虽然是小修，但审稿人真的很认真，两个审稿人共给出30多条意见，细节很多，12天修回后，3天接收, beContent=痞布二马 2020-01-28 23:32:00 发表: 很好的期刊，一审39天给了小修，虽然是小修，但审稿人真的很认真，两个审稿人共给出30多条意见，细节很多，12天修回后，3天接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/09/20/851c1d5009f417324fb4659385cdb06b.jpg, createdBy=a1862291685, createdName=121e9784m68暂无昵称, createdTime=Tue Apr 14 00:00:00 CST 2020, time=2020-04-14, status=1, ipAttribution=)]

2023-06-01 hbzyy 来自上海

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：AD发病机制
经验分享：非常友好期刊，文章质量很好，侧重神经系统疾病发病机制的研究。审稿人也非常友好，提出了很多好的建议

44 0

[GetPortalCommentsPageByObjectIdResponse(id=2184041, encodeId=63552184041ea, content=这个杂志状态是Under Review是不是是内审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ef8420701, createdName=ms5000000487338220, createdTime=Fri Jan 26 09:31:43 CST 2024, time=2024-01-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2180748, encodeId=43f12180e48f4, content=准备投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:35:20 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180747, encodeId=952d2180e4789, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:34:50 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180745, encodeId=d8eb2180e4525, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:34:30 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140289, encodeId=b81d214028956, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：AD发病机制 经验分享：非常友好期刊，文章质量很好，侧重神经系统疾病发病机制的研究。审稿人也非常友好，提出了很多好的建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f491548190, createdName=hbzyy, createdTime=Thu Jun 01 10:50:16 CST 2023, time=2023-06-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1217936, encodeId=1abc121e93659, content=想请问一下这个杂志在投稿过程中Research Square author dashboard这个步骤，会产生pre-print这个东西吗？因为pre-print很麻烦，是无法撤回的。他的选项只有同意，没其他的，选了同意会产生什么不好的结果？谢谢解惑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f716485572, createdName=ms7000001493124412, createdTime=Sun May 08 20:15:36 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217933, encodeId=79fc121e933e4, content=想请问一下各位投稿这个杂志的时候Research Square author dashboard这一步会带来什么影响吗？会不会生成pre-print这个东西？因为pre-print是一个不可逆的步骤, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f716485572, createdName=ms7000001493124412, createdTime=Sun May 08 20:07:33 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107259, encodeId=3f03110e259d2, content=评审和期刊编辑一般会询问什么问题？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107260, encodeId=8b81110e260de, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588816, encodeId=9f6358881649, content=你好，想咨询一下这个杂志对创新性要求高吗？痞布二马 2020-01-28 23:32:00 发表: 很好的期刊，一审39天给了小修，虽然是小修，但审稿人真的很认真，两个审稿人共给出30多条意见，细节很多，12天修回后，3天接收, beContent=痞布二马 2020-01-28 23:32:00 发表: 很好的期刊，一审39天给了小修，虽然是小修，但审稿人真的很认真，两个审稿人共给出30多条意见，细节很多，12天修回后，3天接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/09/20/851c1d5009f417324fb4659385cdb06b.jpg, createdBy=a1862291685, createdName=121e9784m68暂无昵称, createdTime=Tue Apr 14 00:00:00 CST 2020, time=2020-04-14, status=1, ipAttribution=)]

2022-05-08 ms7000001493124412

想请问一下这个杂志在投稿过程中Research Square author dashboard这个步骤，会产生pre-print这个东西吗？因为pre-print很麻烦，是无法撤回的。他的选项只有同意，没其他的，选了同意会产生什么不好的结果？谢谢解惑

43 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2184041, encodeId=63552184041ea, content=这个杂志状态是Under Review是不是是内审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ef8420701, createdName=ms5000000487338220, createdTime=Fri Jan 26 09:31:43 CST 2024, time=2024-01-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2180748, encodeId=43f12180e48f4, content=准备投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:35:20 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180747, encodeId=952d2180e4789, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:34:50 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180745, encodeId=d8eb2180e4525, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:34:30 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140289, encodeId=b81d214028956, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：AD发病机制 经验分享：非常友好期刊，文章质量很好，侧重神经系统疾病发病机制的研究。审稿人也非常友好，提出了很多好的建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f491548190, createdName=hbzyy, createdTime=Thu Jun 01 10:50:16 CST 2023, time=2023-06-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1217936, encodeId=1abc121e93659, content=想请问一下这个杂志在投稿过程中Research Square author dashboard这个步骤，会产生pre-print这个东西吗？因为pre-print很麻烦，是无法撤回的。他的选项只有同意，没其他的，选了同意会产生什么不好的结果？谢谢解惑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f716485572, createdName=ms7000001493124412, createdTime=Sun May 08 20:15:36 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217933, encodeId=79fc121e933e4, content=想请问一下各位投稿这个杂志的时候Research Square author dashboard这一步会带来什么影响吗？会不会生成pre-print这个东西？因为pre-print是一个不可逆的步骤, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f716485572, createdName=ms7000001493124412, createdTime=Sun May 08 20:07:33 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107259, encodeId=3f03110e259d2, content=评审和期刊编辑一般会询问什么问题？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107260, encodeId=8b81110e260de, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588816, encodeId=9f6358881649, content=你好，想咨询一下这个杂志对创新性要求高吗？痞布二马 2020-01-28 23:32:00 发表: 很好的期刊，一审39天给了小修，虽然是小修，但审稿人真的很认真，两个审稿人共给出30多条意见，细节很多，12天修回后，3天接收, beContent=痞布二马 2020-01-28 23:32:00 发表: 很好的期刊，一审39天给了小修，虽然是小修，但审稿人真的很认真，两个审稿人共给出30多条意见，细节很多，12天修回后，3天接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/09/20/851c1d5009f417324fb4659385cdb06b.jpg, createdBy=a1862291685, createdName=121e9784m68暂无昵称, createdTime=Tue Apr 14 00:00:00 CST 2020, time=2020-04-14, status=1, ipAttribution=)]

2022-05-08 ms7000001493124412

想请问一下各位投稿这个杂志的时候Research Square author dashboard这一步会带来什么影响吗？会不会生成pre-print这个东西？因为pre-print是一个不可逆的步骤

38 0

[GetPortalCommentsPageByObjectIdResponse(id=2184041, encodeId=63552184041ea, content=这个杂志状态是Under Review是不是是内审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ef8420701, createdName=ms5000000487338220, createdTime=Fri Jan 26 09:31:43 CST 2024, time=2024-01-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2180748, encodeId=43f12180e48f4, content=准备投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:35:20 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180747, encodeId=952d2180e4789, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:34:50 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180745, encodeId=d8eb2180e4525, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:34:30 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140289, encodeId=b81d214028956, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：AD发病机制 经验分享：非常友好期刊，文章质量很好，侧重神经系统疾病发病机制的研究。审稿人也非常友好，提出了很多好的建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f491548190, createdName=hbzyy, createdTime=Thu Jun 01 10:50:16 CST 2023, time=2023-06-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1217936, encodeId=1abc121e93659, content=想请问一下这个杂志在投稿过程中Research Square author dashboard这个步骤，会产生pre-print这个东西吗？因为pre-print很麻烦，是无法撤回的。他的选项只有同意，没其他的，选了同意会产生什么不好的结果？谢谢解惑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f716485572, createdName=ms7000001493124412, createdTime=Sun May 08 20:15:36 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217933, encodeId=79fc121e933e4, content=想请问一下各位投稿这个杂志的时候Research Square author dashboard这一步会带来什么影响吗？会不会生成pre-print这个东西？因为pre-print是一个不可逆的步骤, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f716485572, createdName=ms7000001493124412, createdTime=Sun May 08 20:07:33 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107259, encodeId=3f03110e259d2, content=评审和期刊编辑一般会询问什么问题？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107260, encodeId=8b81110e260de, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588816, encodeId=9f6358881649, content=你好，想咨询一下这个杂志对创新性要求高吗？痞布二马 2020-01-28 23:32:00 发表: 很好的期刊，一审39天给了小修，虽然是小修，但审稿人真的很认真，两个审稿人共给出30多条意见，细节很多，12天修回后，3天接收, beContent=痞布二马 2020-01-28 23:32:00 发表: 很好的期刊，一审39天给了小修，虽然是小修，但审稿人真的很认真，两个审稿人共给出30多条意见，细节很多，12天修回后，3天接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/09/20/851c1d5009f417324fb4659385cdb06b.jpg, createdBy=a1862291685, createdName=121e9784m68暂无昵称, createdTime=Tue Apr 14 00:00:00 CST 2020, time=2020-04-14, status=1, ipAttribution=)]

2021-12-29 Gym璨烨

评审和期刊编辑一般会询问什么问题？

62 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2184041, encodeId=63552184041ea, content=这个杂志状态是Under Review是不是是内审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ef8420701, createdName=ms5000000487338220, createdTime=Fri Jan 26 09:31:43 CST 2024, time=2024-01-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2180748, encodeId=43f12180e48f4, content=准备投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:35:20 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180747, encodeId=952d2180e4789, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:34:50 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180745, encodeId=d8eb2180e4525, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:34:30 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140289, encodeId=b81d214028956, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：AD发病机制 经验分享：非常友好期刊，文章质量很好，侧重神经系统疾病发病机制的研究。审稿人也非常友好，提出了很多好的建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f491548190, createdName=hbzyy, createdTime=Thu Jun 01 10:50:16 CST 2023, time=2023-06-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1217936, encodeId=1abc121e93659, content=想请问一下这个杂志在投稿过程中Research Square author dashboard这个步骤，会产生pre-print这个东西吗？因为pre-print很麻烦，是无法撤回的。他的选项只有同意，没其他的，选了同意会产生什么不好的结果？谢谢解惑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f716485572, createdName=ms7000001493124412, createdTime=Sun May 08 20:15:36 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217933, encodeId=79fc121e933e4, content=想请问一下各位投稿这个杂志的时候Research Square author dashboard这一步会带来什么影响吗？会不会生成pre-print这个东西？因为pre-print是一个不可逆的步骤, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f716485572, createdName=ms7000001493124412, createdTime=Sun May 08 20:07:33 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107259, encodeId=3f03110e259d2, content=评审和期刊编辑一般会询问什么问题？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107260, encodeId=8b81110e260de, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588816, encodeId=9f6358881649, content=你好，想咨询一下这个杂志对创新性要求高吗？痞布二马 2020-01-28 23:32:00 发表: 很好的期刊，一审39天给了小修，虽然是小修，但审稿人真的很认真，两个审稿人共给出30多条意见，细节很多，12天修回后，3天接收, beContent=痞布二马 2020-01-28 23:32:00 发表: 很好的期刊，一审39天给了小修，虽然是小修，但审稿人真的很认真，两个审稿人共给出30多条意见，细节很多，12天修回后，3天接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/09/20/851c1d5009f417324fb4659385cdb06b.jpg, createdBy=a1862291685, createdName=121e9784m68暂无昵称, createdTime=Tue Apr 14 00:00:00 CST 2020, time=2020-04-14, status=1, ipAttribution=)]

2021-12-29 衣谷

评审和期刊编辑要求我补实验，就一定要补么，不补行不行？

49 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2184041, encodeId=63552184041ea, content=这个杂志状态是Under Review是不是是内审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ef8420701, createdName=ms5000000487338220, createdTime=Fri Jan 26 09:31:43 CST 2024, time=2024-01-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2180748, encodeId=43f12180e48f4, content=准备投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:35:20 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180747, encodeId=952d2180e4789, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:34:50 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180745, encodeId=d8eb2180e4525, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:34:30 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140289, encodeId=b81d214028956, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：AD发病机制 经验分享：非常友好期刊，文章质量很好，侧重神经系统疾病发病机制的研究。审稿人也非常友好，提出了很多好的建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f491548190, createdName=hbzyy, createdTime=Thu Jun 01 10:50:16 CST 2023, time=2023-06-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1217936, encodeId=1abc121e93659, content=想请问一下这个杂志在投稿过程中Research Square author dashboard这个步骤，会产生pre-print这个东西吗？因为pre-print很麻烦，是无法撤回的。他的选项只有同意，没其他的，选了同意会产生什么不好的结果？谢谢解惑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f716485572, createdName=ms7000001493124412, createdTime=Sun May 08 20:15:36 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217933, encodeId=79fc121e933e4, content=想请问一下各位投稿这个杂志的时候Research Square author dashboard这一步会带来什么影响吗？会不会生成pre-print这个东西？因为pre-print是一个不可逆的步骤, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f716485572, createdName=ms7000001493124412, createdTime=Sun May 08 20:07:33 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107259, encodeId=3f03110e259d2, content=评审和期刊编辑一般会询问什么问题？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107260, encodeId=8b81110e260de, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588816, encodeId=9f6358881649, content=你好，想咨询一下这个杂志对创新性要求高吗？痞布二马 2020-01-28 23:32:00 发表: 很好的期刊，一审39天给了小修，虽然是小修，但审稿人真的很认真，两个审稿人共给出30多条意见，细节很多，12天修回后，3天接收, beContent=痞布二马 2020-01-28 23:32:00 发表: 很好的期刊，一审39天给了小修，虽然是小修，但审稿人真的很认真，两个审稿人共给出30多条意见，细节很多，12天修回后，3天接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/09/20/851c1d5009f417324fb4659385cdb06b.jpg, createdBy=a1862291685, createdName=121e9784m68暂无昵称, createdTime=Tue Apr 14 00:00:00 CST 2020, time=2020-04-14, status=1, ipAttribution=)]

2020-04-14 121e9784m68暂无昵称

你好，想咨询一下这个杂志对创新性要求高吗？痞布二马 2020-01-28 23:32:00 发表:
很好的期刊，一审39天给了小修，虽然是小修，但审稿人真的很认真，两个审稿人共给出30多条意见，细节很多，12天修回后，3天接收

痞布二马 2020-01-28 23:32:00 发表: 很好的期刊，一审39天给了小修，虽然是小修，但审稿人真的很认真，两个审稿人共给出30多条意见，细节很多，12天修回后，3天接收

84 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务